Clinical Trials Search Tool
Mild-to-Severe Atopic Dermatitis
Enrollment Opens: 01-24-2022
Enrollment Closes: TBD
This is a study to investigate the effect of an investigational oral medication in participants for the treatment of mild, moderate and severe atopic dermatitis. With successful completion of this study, there is also a longer term extension study for qualified participants.
Study ID: OMRC-000130
To Enroll: Visit http://www.oregonmedicalresearch.com to learn more and fill out the contact form, or call 503-245-1525 to contact us directly.
Posted by: Oregon Medical Research Center | http://www.oregonmedicalresearch.com